Matthew B. Buechler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Matthew B. Buechler has a total of 302 co-authors. Here are the top co-authors by number of shared publications:
- Shannon. J. Turley
Genentech, South San Francisco, CA
9 shared publications Erika E. McCartney
Department of Immunology, University of Toronto. Toronto, Ontario, Canada
5 shared publicationsMaye F. Cheng
Department of Immunology, University of Toronto, Toronto, Canada
5 shared publicationsNancy A. Wilson
Wisconsin National Primate Center, University of Wisconsin, Madison, Wisconsin, United States of America
5 shared publicationsYein Chung
Department of Immunology, University of Toronto, Toronto, Ontario, Canada
5 shared publicationsAnthony Altieri
Department of Immunology, University of Toronto. Toronto, Ontario, Canada
4 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (11) , 2351
Author Correction: A novel CAF population coordinates hyper-suppressive regulatory T cell recruitment and localization in lung cancer
- 10 September 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (11) , 2351
Open AccessAuthor Correction: A novel CAF population coordinates hyper-suppressive regulatory T cell recruitment and localization in lung cancer
- Open Access
- 11 August 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (9) , 1899-1912
A novel CAF population coordinates hyper-suppressive regulatory T cell recruitment and localization in lung cancer
Across many solid tumor types, cancer-associated fibroblasts (CAFs) are abundant and heterogeneous, with distinct subpopulations exerting immunomodulatory functions. Here we identify a novel population of immunomodulatory CAFs (imCAFs) in primary lung adenocarcinoma and pulmonary metastases, characterized by cell adhesion molecule L1-like (CHL1) expression and enriched in immune regulation and chemokine signaling programs. Through single-cell and spatial transcriptomics, we demonstrate that imCAFs are spatially colocalized with CXCR3 + regulatory T (T reg ) cells, a hyper-suppressive subset accumulating at the tumor border. imCAFs produce CXCL9, driving CXCR3 + T reg cell recruitment and promoting an immunosuppressive microenvironment. CXCR3 + T reg cells display enhanced proliferative and suppressive capacity and are transcriptionally distinct from CXCR3 − counterparts. Genetic ablation of Cxcr3 in T reg cells or Cxcl9 in stromal cells reduces T reg cell accumulation, enhances CD8 + T cell activation and decreases tumor burden. Analogous CHL1 + imCAF-like fibroblasts in human non-small cell lung cancer colocalize with T reg cells, and elevated CHL1 expression is associated with reduced cytotoxicity and decreased progression-free survival, highlighting the imCAF–CXCL9–CXCR3 + T reg axis as a promising therapeutic target.
- 11 August 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (9) , 1899-1912
Open AccessA novel CAF population coordinates hyper-suppressive regulatory T cell recruitment and localization in lung cancer
Across many solid tumor types, cancer-associated fibroblasts (CAFs) are abundant and heterogeneous, with distinct subpopulations exerting immunomodulatory functions. Here we identify a novel population of immunomodulatory CAFs (imCAFs) in primary lung adenocarcinoma and pulmonary metastases, characterized by cell adhesion molecule L1-like (CHL1) expression and enriched in immune regulation and chemokine signaling programs. Through single-cell and spatial transcriptomics, we demonstrate that imCAFs are spatially colocalized with CXCR3 + regulatory T (T reg ) cells, a hyper-suppressive subset accumulating at the tumor border. imCAFs produce CXCL9, driving CXCR3 + T reg cell recruitment and promoting an immunosuppressive microenvironment. CXCR3 + T reg cells display enhanced proliferative and suppressive capacity and are transcriptionally distinct from CXCR3 − counterparts. Genetic ablation of Cxcr3 in T reg cells or Cxcl9 in stromal cells reduces T reg cell accumulation, enhances CD8 + T cell activation and decreases tumor burden. Analogous CHL1 + imCAF-like fibroblasts in human non-small cell lung cancer colocalize with T reg cells, and elevated CHL1 expression is associated with reduced cytotoxicity and decreased progression-free survival, highlighting the imCAF–CXCL9–CXCR3 + T reg axis as a promising therapeutic target.
- 2 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6806) , eaea5113
ILC2s regulate a fibroblast progenitor niche in the pancreas
Local fibroblast development and densities influence organ health and disease, although it remains unclear how tissue fibroblast topography is controlled in situ. Here, we defined Group 2 innate lymphoid cells (ILC2s) as key regulators of fibroblast homeostasis in the pancreas. ILC2s colocalized with fibroblasts expressing the genes Pi16 + Dpp4 + Ly6c + in an interstitial niche of the exocrine pancreas, which encapsulates the organ parenchyma. ILC2s specifically regulated the expansion of Pi16 + Dpp4 + Ly6c + fibroblasts, which have progenitor capacity, while restraining differentiated intraparenchymal Col15a1 + fibroblasts during inflammation. These circuits reinforced fibroblast numbers after injury and set an inflammatory threshold. The ILC2 and Pi16 + Dpp4 + Ly6c + fibroblast progenitor niche expanded around tumors and controlled cancer-associated fibroblast ontogeny and density. Hence, ILC2-fibroblast dialogue represents a regulatory node that locally orchestrates tissue homeostasis and pathology.
- 2 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6806) , eaea5113
ILC2s regulate a fibroblast progenitor niche in the pancreas
Local fibroblast development and densities influence organ health and disease, although it remains unclear how tissue fibroblast topography is controlled in situ. Here, we defined Group 2 innate lymphoid cells (ILC2s) as key regulators of fibroblast homeostasis in the pancreas. ILC2s colocalized with fibroblasts expressing the genes Pi16 + Dpp4 + Ly6c + in an interstitial niche of the exocrine pancreas, which encapsulates the organ parenchyma. ILC2s specifically regulated the expansion of Pi16 + Dpp4 + Ly6c + fibroblasts, which have progenitor capacity, while restraining differentiated intraparenchymal Col15a1 + fibroblasts during inflammation. These circuits reinforced fibroblast numbers after injury and set an inflammatory threshold. The ILC2 and Pi16 + Dpp4 + Ly6c + fibroblast progenitor niche expanded around tumors and controlled cancer-associated fibroblast ontogeny and density. Hence, ILC2-fibroblast dialogue represents a regulatory node that locally orchestrates tissue homeostasis and pathology.
- Open Access
Pi16 + fibroblast-derived Csf1 shapes skin topography
Peptidase inhibitor 16 ( Pi16 )-expressing fibroblasts are found across tissues and species, but their functional role is unclear. As fibroblasts and macrophages have been proposed to exist in a reciprocal circuit, we hypothesized Pi16 + fibroblasts may regulate macrophage homeostasis. Flow cytometry revealed ∼80% of skin fibroblasts express Pi16 , leading us to investigate the role of these cells in maintaining a macrophage niche in this tissue. We generated an in vivo system where fibroblast-derived Colony Stimulating Factor 1 ( Csf1) was constitutively eliminated in Pi16 + fibroblasts by crossing animals with a Csf1fl/fl allele to mice in which the gene Pi16 drives an IresCre cassette. Deletion of Csf1 in Pi16 + fibroblasts resulted in significant diminishment of CD64 + and CD11c + macrophages alongside expansion of PDPN + YFP + fibroblasts. Alterations in cell population dynamics coincided with thickening of both the dermis and fascial compartments of the skin. Deletion of Csf1 in Pi16 + fibroblasts delayed early wound healing in a unsplinted mouse model. Loss of PI16 + fibroblasts was observed in individuals with limited (lSSc) and diffuse (dSSc) systemic Scleroderma compared to healthy controls. These findings suggest that loss of Csf1 in Pi16 + fibroblasts elicit changes in the population dynamics of skin macrophages and modifications to tissue architecture.
Open AccessPi16 + fibroblast-derived Csf1 shapes skin topography
Peptidase inhibitor 16 ( Pi16 )-expressing fibroblasts are found across tissues and species, but their functional role is unclear. As fibroblasts and macrophages have been proposed to exist in a reciprocal circuit, we hypothesized Pi16 + fibroblasts may regulate macrophage homeostasis. Flow cytometry revealed ∼80% of skin fibroblasts express Pi16 , leading us to investigate the role of these cells in maintaining a macrophage niche in this tissue. We generated an in vivo system where fibroblast-derived Colony Stimulating Factor 1 ( Csf1) was constitutively eliminated in Pi16 + fibroblasts by crossing animals with a Csf1fl/fl allele to mice in which the gene Pi16 drives an IresCre cassette. Deletion of Csf1 in Pi16 + fibroblasts resulted in significant diminishment of CD64 + and CD11c + macrophages alongside expansion of PDPN + YFP + fibroblasts. Alterations in cell population dynamics coincided with thickening of both the dermis and fascial compartments of the skin. Deletion of Csf1 in Pi16 + fibroblasts delayed early wound healing in a unsplinted mouse model. Loss of PI16 + fibroblasts was observed in individuals with limited (lSSc) and diffuse (dSSc) systemic Scleroderma compared to healthy controls. These findings suggest that loss of Csf1 in Pi16 + fibroblasts elicit changes in the population dynamics of skin macrophages and modifications to tissue architecture.
- Top Cited PapersOpen Access
- 27 February 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (4) , 700-714
Reciprocal regulation of fibroblast–macrophage equilibrium governs skin integrity
Fibroblast-macrophage crosstalk is well-established in vitro, and fibroblast-derived colony-stimulating factor 1 (CSF1) supports macrophages in select tissues. However, whether macrophages regulate fibroblasts in vivo remains unknown. Leveraging genetic mouse models, single-cell multi-omics, flow cytometry and imaging, we show that fibroblast depletion or loss of fibroblast-derived growth factors impacts skin macrophage populations in the dermis and hypodermis. Conditional deletion of Csf1 in Dpt+ fibroblasts progressively decreases CD64+ and CD11c+ macrophages, impairing skin wound healing. Reduced macrophage abundance disrupts fibroblast cell cycle regulation, metabolism and immune signaling, and increases fibroblast abundance, affirming a reciprocal relationship. In human systemic sclerosis (scleroderma), elevated fibroblast-derived CSF1 and increased macrophage abundance correlate with disease severity, implicating the CSF1-CSF1R axis in pathology. These findings provide in vivo evidence of macrophage regulation of fibroblasts, revealing a bidirectional interplay that advances understanding of tissue homeostasis and immune regulation in skin.
- 27 February 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (4) , 700-714
Top Cited PapersOpen AccessReciprocal regulation of fibroblast–macrophage equilibrium governs skin integrity
Fibroblast-macrophage crosstalk is well-established in vitro, and fibroblast-derived colony-stimulating factor 1 (CSF1) supports macrophages in select tissues. However, whether macrophages regulate fibroblasts in vivo remains unknown. Leveraging genetic mouse models, single-cell multi-omics, flow cytometry and imaging, we show that fibroblast depletion or loss of fibroblast-derived growth factors impacts skin macrophage populations in the dermis and hypodermis. Conditional deletion of Csf1 in Dpt+ fibroblasts progressively decreases CD64+ and CD11c+ macrophages, impairing skin wound healing. Reduced macrophage abundance disrupts fibroblast cell cycle regulation, metabolism and immune signaling, and increases fibroblast abundance, affirming a reciprocal relationship. In human systemic sclerosis (scleroderma), elevated fibroblast-derived CSF1 and increased macrophage abundance correlate with disease severity, implicating the CSF1-CSF1R axis in pathology. These findings provide in vivo evidence of macrophage regulation of fibroblasts, revealing a bidirectional interplay that advances understanding of tissue homeostasis and immune regulation in skin.
- Open Access
- 22 December 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (24)
Identification of Ephrin type-B receptor 4 as a critical mediator of tissue fibrosis
Pulmonary fibrosis (PF) is a pathology associated with interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF). Fibrosis promotes continual secretion of extracellular matrix (ECM), producing nonfunctional scar tissue and causing organ failure. This study investigated the tyrosine kinase receptor Ephrin type-B receptor 4 (EphB4) as a mediator of PF. To this end, we generated mice with conditional Col1a2- driven deletion of Ephb4 and used a preclinical mouse model of PF, total and single nuclei RNA (snRNA) sequencing, NanoString, previously published single-cell data, computational analysis, and functional assays of mouse and human healthy control and IPF lung fibroblasts. Col1a2 -Cre ERT –driven Ephb4 deletion, or EphB4 inhibition via NVP-BHG712, markedly protected against bleomycin-induced PF. Total RNA-Seq of fibroblasts isolated from Ephb4 -deficient fibrotic mouse lungs exhibited reduced expression of ECM, ER Cargo, and protein trafficking–related genes. NVP-BHG712 reduced expression of these identified genes in mouse lung fibroblasts under fibrotic conditions in vitro. snRNA-Seq of mouse lungs treated with NVP-BHG712 identified transcriptomic changes of ECM genes in specific fibroblast subpopulations. RNA-Seq, computational, and functional assays using mouse and human IPF fibroblasts identified elastin as a key mediator involved in EphB4 signaling. Combined, our data show that EphB4 is a crucial mediator of PF.
- 22 December 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (24)
Open AccessIdentification of Ephrin type-B receptor 4 as a critical mediator of tissue fibrosis
Pulmonary fibrosis (PF) is a pathology associated with interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF). Fibrosis promotes continual secretion of extracellular matrix (ECM), producing nonfunctional scar tissue and causing organ failure. This study investigated the tyrosine kinase receptor Ephrin type-B receptor 4 (EphB4) as a mediator of PF. To this end, we generated mice with conditional Col1a2- driven deletion of Ephb4 and used a preclinical mouse model of PF, total and single nuclei RNA (snRNA) sequencing, NanoString, previously published single-cell data, computational analysis, and functional assays of mouse and human healthy control and IPF lung fibroblasts. Col1a2 -Cre ERT –driven Ephb4 deletion, or EphB4 inhibition via NVP-BHG712, markedly protected against bleomycin-induced PF. Total RNA-Seq of fibroblasts isolated from Ephb4 -deficient fibrotic mouse lungs exhibited reduced expression of ECM, ER Cargo, and protein trafficking–related genes. NVP-BHG712 reduced expression of these identified genes in mouse lung fibroblasts under fibrotic conditions in vitro. snRNA-Seq of mouse lungs treated with NVP-BHG712 identified transcriptomic changes of ECM genes in specific fibroblast subpopulations. RNA-Seq, computational, and functional assays using mouse and human IPF fibroblasts identified elastin as a key mediator involved in EphB4 signaling. Combined, our data show that EphB4 is a crucial mediator of PF.
- Open Access
Bigh3 is essential for pulmonary fibrosis
Transforming growth factor beta (TGF- β) -induced g ene- h uman, clone 3 (BIGH3) has been implicated as a biomarker of lung fibrosis. However, it is unknown if BIGH3 plays a functional role in fibrosis pathogenesis. To address this question, we used in silico , in vitro and in vivo approaches. We found that BIGH3 / Bigh3 is upregulated in human lung fibrosis and mouse models of pulmonary fibrosis. We next generated a novel Bigh3 knockout ( Bigh3 −/− ) mouse and found that while these animals exhibited lung architecture and immune cellularity that is broadly equivalent to wild-type mice, they were protected from lung fibrosis in response to bleomycin administration. In silico modeling suggested that BIGH3 can bind to integrin alpha v (ITGAV). In vitro co-culture systems revealed that activated human lung fibroblasts can elicit BIGH3 expression from human monocyte-derived macrophages. Last, macrophages elicited collagen expression from lung fibroblasts in a manner that is Bigh3 -dependent. Collectively, these data suggest that Bigh3 is a product of fibroblast-macrophage interactions that is essential for the pathogenesis of lung fibrosis, possibly via interactions with ITGAV.
Open AccessBigh3 is essential for pulmonary fibrosis
Transforming growth factor beta (TGF- β) -induced g ene- h uman, clone 3 (BIGH3) has been implicated as a biomarker of lung fibrosis. However, it is unknown if BIGH3 plays a functional role in fibrosis pathogenesis. To address this question, we used in silico , in vitro and in vivo approaches. We found that BIGH3 / Bigh3 is upregulated in human lung fibrosis and mouse models of pulmonary fibrosis. We next generated a novel Bigh3 knockout ( Bigh3 −/− ) mouse and found that while these animals exhibited lung architecture and immune cellularity that is broadly equivalent to wild-type mice, they were protected from lung fibrosis in response to bleomycin administration. In silico modeling suggested that BIGH3 can bind to integrin alpha v (ITGAV). In vitro co-culture systems revealed that activated human lung fibroblasts can elicit BIGH3 expression from human monocyte-derived macrophages. Last, macrophages elicited collagen expression from lung fibroblasts in a manner that is Bigh3 -dependent. Collectively, these data suggest that Bigh3 is a product of fibroblast-macrophage interactions that is essential for the pathogenesis of lung fibrosis, possibly via interactions with ITGAV.
- 31 January 2025
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 25 (3) , 160
Podoplanin mediates stromal–immune crosstalk in the lymph node
- 31 January 2025
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 25 (3) , 160
Podoplanin mediates stromal–immune crosstalk in the lymph node
- Open Access
- 5 December 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 119
Enter the Matrix: Fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease.
Fibroblasts, non-hematopoietic cells of mesenchymal origin, are tissue architects which regulate the topography of tissues, dictate tissue resident cell types, and drive fibrotic disease. Fibroblasts regulate the composition of the extracellular matrix (ECM), a 3-dimensional network of macromolecules that comprise the acellular milieu of tissues. Fibroblasts can directly and indirectly regulate immune responses by secreting ECM and ECM-bound molecules to shape tissue structure and influence organ function. In this review, we will highlight recent studies which elucidate the mechanisms by which fibroblast-derived ECM factors (e.g., collagens, fibrillar proteins) regulate ECM architecture and subsequent immune responses, with a focus on macrophages. As examples of fibroblast-derived ECM proteins, we examine Collagen Triple Helix Repeat Containing 1 (CTHRC1) and Transforming Growth Factor-β-inducible protein (TGFBI), also known as BIGH3. We address the need for investigation into how diverse fibroblast populations coordinate immune responses by modulating ECM, including the fibroblast-ECM-immune axis and the precise molecular mediators and pathways which regulate these processes. Finally, we will outline how novel research identifying key regulators of ECM deposition is critical for therapeutic development for fibrotic diseases and cancer.
- 5 December 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 119
Open AccessEnter the Matrix: Fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease.
Fibroblasts, non-hematopoietic cells of mesenchymal origin, are tissue architects which regulate the topography of tissues, dictate tissue resident cell types, and drive fibrotic disease. Fibroblasts regulate the composition of the extracellular matrix (ECM), a 3-dimensional network of macromolecules that comprise the acellular milieu of tissues. Fibroblasts can directly and indirectly regulate immune responses by secreting ECM and ECM-bound molecules to shape tissue structure and influence organ function. In this review, we will highlight recent studies which elucidate the mechanisms by which fibroblast-derived ECM factors (e.g., collagens, fibrillar proteins) regulate ECM architecture and subsequent immune responses, with a focus on macrophages. As examples of fibroblast-derived ECM proteins, we examine Collagen Triple Helix Repeat Containing 1 (CTHRC1) and Transforming Growth Factor-β-inducible protein (TGFBI), also known as BIGH3. We address the need for investigation into how diverse fibroblast populations coordinate immune responses by modulating ECM, including the fibroblast-ECM-immune axis and the precise molecular mediators and pathways which regulate these processes. Finally, we will outline how novel research identifying key regulators of ECM deposition is critical for therapeutic development for fibrotic diseases and cancer.
- Open Access
Dermatopontin-expressing fibroblasts mediate an essential skin macrophage niche
Fibroblasts are present in all tissues and are crucial for maintaining tissue homeostasis. We previously identified fibroblasts marked by Dermatopontin ( Dpt ) but their role in supporting macrophage homeostasis remains unclear. Here, we generated novel mesenchymal lineage-restricted genetic tools to target Dpt expressing fibroblasts and elucidate their role in supporting skin macrophages. Transcriptional profiling, flow cytometry, and in situ hybridization uncovered two broad populations of F4/80-expressing skin macrophages, denoted by high expression of CD206 and CD64 (CD206 hi CD64+), or CD11c. Targeted depletion of Dpt + fibroblasts resulted in a profound loss of both macrophage populations. Conditional deletion of colony-stimulating factor-1 ( Csf1) in Dpt + fibroblasts revealed that CD206 hi CD64+, and not CD11c+, macrophages are acutely dependent on fibroblast-derived Csf1 , consistent with their higher expression of the Csf1 receptor. Following Csf1 deletion in Dpt + fibroblasts, loss of CD206 hi CD64+ macrophages were observed across the dermis, dermal white adipose tissue (dWAT), and adventitia, accompanied by a modest upregulation of fibroblast-related and extracellular matrix (ECM) genes and structural changes to the skin. Alterations to the skin network upon loss of fibroblast-derived Csf1 and CD206 hi CD64+ macrophages led to a significant delay in wound healing. We also demonstrate the CSF1-CSF1R signaling pathway is functionally relevant in human systemic sclerosis, or scleroderma, as elevated levels of CSF1 produced by fibroblasts and an increased abundance of macrophages both correlate with disease severity. Our findings demonstrate the role of Dpt + fibroblasts in regulating a Csf1 -dependent macrophage niche in skin and orchestrating responses in injury and disease.
Open AccessDermatopontin-expressing fibroblasts mediate an essential skin macrophage niche
Fibroblasts are present in all tissues and are crucial for maintaining tissue homeostasis. We previously identified fibroblasts marked by Dermatopontin ( Dpt ) but their role in supporting macrophage homeostasis remains unclear. Here, we generated novel mesenchymal lineage-restricted genetic tools to target Dpt expressing fibroblasts and elucidate their role in supporting skin macrophages. Transcriptional profiling, flow cytometry, and in situ hybridization uncovered two broad populations of F4/80-expressing skin macrophages, denoted by high expression of CD206 and CD64 (CD206 hi CD64+), or CD11c. Targeted depletion of Dpt + fibroblasts resulted in a profound loss of both macrophage populations. Conditional deletion of colony-stimulating factor-1 ( Csf1) in Dpt + fibroblasts revealed that CD206 hi CD64+, and not CD11c+, macrophages are acutely dependent on fibroblast-derived Csf1 , consistent with their higher expression of the Csf1 receptor. Following Csf1 deletion in Dpt + fibroblasts, loss of CD206 hi CD64+ macrophages were observed across the dermis, dermal white adipose tissue (dWAT), and adventitia, accompanied by a modest upregulation of fibroblast-related and extracellular matrix (ECM) genes and structural changes to the skin. Alterations to the skin network upon loss of fibroblast-derived Csf1 and CD206 hi CD64+ macrophages led to a significant delay in wound healing. We also demonstrate the CSF1-CSF1R signaling pathway is functionally relevant in human systemic sclerosis, or scleroderma, as elevated levels of CSF1 produced by fibroblasts and an increased abundance of macrophages both correlate with disease severity. Our findings demonstrate the role of Dpt + fibroblasts in regulating a Csf1 -dependent macrophage niche in skin and orchestrating responses in injury and disease.